Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17751704 | 0.93 | MDM4 (0.43) | MDM4TP53MDM2TLR2PTPN1 | |
| SCHEMBL16289312 | 0.92 | MDM4 (0.47) | MDM4TP53MDM2CASP3 | |
| SCHEMBL31591669 | 0.89 | MDM4 (0.46) | MDM4TP53MDM2TLR2PTPN1 | |
| SCHEMBL16574818 | 0.88 | MDM4 (0.45) | MDM4TP53MDM2CASP3 | |
| SCHEMBL27728772 | 0.86 | MDM4 (0.49) | MDM4TP53MDM2TLR2CASP3 | |
| SCHEMBL13049087 | 0.85 | TLR2 (0.47) | MDM4TP53MDM2TLR2 | |
| SCHEMBL12621110 | 0.85 | MDM4 (0.45) | MDM4TP53MDM2CASP3 | |
| SCHEMBL8242447 | 0.84 | MDM4 (0.43) | MDM4TP53MDM2TLR2CASP3 | |
| SCHEMBL23157111 | 0.83 | MDM4 (0.41) | MDM4TP53MDM2CASP3 | |
| SCHEMBL17751711 | 0.83 | TLR2 (0.40) | MDM4TP53MDM2TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096921-A1 | PEPTIDE ACIDS AS A GLP1R AGONIST AND ANTIBODY-DRUG CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |